Knowledge hub

Pulmonary & nasal delivery capabilities 

Get an overview of our pulmonary & nasal delivery capabilities, including:  Customized approach to determining the right device for your drug  Pulmonary & nasal platform technologies: pressurized metered-dose inhaler (pMDI), dry power inhaler (DPI), soft-mist inhaler (SMI), nebulizer, and nasal spray  Green propellant innovations  Experience bringing complex generics to market  Expansive capabilities across state-of-the-art facilities […]

Global health security capabilities 

Meridian Medical Technologies, the global health security business unit within Kindeva Drug Delivery, has been a global force in medical countermeasure development, manufacturing, and supply for 60+ years.

Your leading global CDMO 

See our range of CDMO services and learn how we can bring your therapy to the world. Our platform technologies span pulmonary & nasal, injectable, and transdermal delivery, with services for every stage of combination product development & manufacturing. Discover how you can combine forces with us.

The evolution of pulmonary & nasal drug delivery

Physicians have treated illness with inhaled remedies for thousands of years. The pressurized metered-dose inhalers (pMDIs) used today differ dramatically from the pipes, reeds, and pots used centuries ago, but the benefits of inhalation devices have stood the test of time. As the inventors of the original pMDI, Kindeva draws on this legacy to develop […]

What happens when large-scale manufacturing meets full-service CDMO capabilities?

In the ever-evolving pharmaceutical and biotechnology industries, the demand for seamless integration between large-scale manufacturing and full-service CDMO capabilities has never been more critical. In this article by Chad Hafer, discover how access to the process, range of services, and capacity is crucial to minimize risk, lower costs, and streamline timelines through every stage of […]

What’s next for CDMO supply chains?

How CDMOs Can Develop a More Seamless Supply Chain Recent pharmaceutical industry market dynamics have tested the resolve of contract development and manufacturing organizations (CDMOs) of all sizes. To maintain business vitality, several CDMOs have been forced to consider the difficult decision to stop manufacturing products that are too complex or too expensive to make […]

Missed ss at DDL? Unlock pulmonary & nasal insights with our presentations 

Kindeva Drug Delivery presented cutting-edge advancements in pulmonary & nasal development and manufacturing at the Drug Delivery to the Lungs (DDL) conference on December 6-8, 2023. Across eight posters and podium presentations, we highlighted strategies for switching to green propellant formulations while preserving product performance, among a variety of other topics. If you missed any […]

Manufacturing microneedle products presentation

Access Now

The pMDI dilemma: managing patient needs, human health, and the planet